Clinical trial
Synuclein-One Study
NCT04700722
Study timeline
Study start (actual)2021-01-04Date precision: day
Registry last updated2024-01-03
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Parkinson Diseaseunresolved
Multiple System Atrophyunresolved
Dementia With Lewy Bodiesunresolved
Pure Autonomic Failureunresolved
Interventions
Skin BiopsyDIAGNOSTIC_TEST
Sponsors & collaborators
CND Life Scienceslead sponsor
Mapped research locations
BostonMassachusetts, United States2New YorkNew York, United States1DallasTexas, United States1NashvilleTennessee, United States1SeattleWashington, United States1PortlandOregon, United States1DurhamNorth Carolina, United States1PhoenixArizona, United States1RochesterMinnesota, United States1GainesvilleFlorida, United States1ScottsdaleArizona, United States1Boca RatonFlorida, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04700722 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.